Ventuno Biotech

Lyon, France

Ventuno Biotech is a biotech company that is developing innovative cancer therapies.

$2.3M raised

Nov 2025

Seed

Biotechnology Consumer Research Medical

Top Investors

BNP ParibasRelyensCaisse d'Epargne Rhone AlpesOctalfaArmand Bensussan

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ventuno Biotech

How much funding has Ventuno Biotech raised?

Ventuno Biotech has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Ventuno Biotech's investors?

Ventuno Biotech's investors include BNP Paribas, Relyens, Caisse d'Epargne Rhone Alpes, Octalfa, Armand Bensussan.

Where is Ventuno Biotech headquartered?

Ventuno Biotech is headquartered in Lyon, France.

What does Ventuno Biotech do?

Ventuno Biotech is a biotech company that is developing innovative cancer therapies.

What stage is Ventuno Biotech at?

Ventuno Biotech is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 26, 2025.

MLA

"Ventuno Biotech — Funding & Investors." VCBacked, November 26, 2025, https://www.vcbacked.co/company/ventuno-biotech. Accessed June 17, 2026.

APA

VCBacked. (2025). Ventuno Biotech — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/ventuno-biotech

Wikipedia (cite web)

{{cite web |title=Ventuno Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ventuno-biotech |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 26, 2025.

Similar Companies in Biotechnology